glp 1 nerve pain Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment The Impact of GLP-1 Receptor

10.1007/s00125-019-05039-w 14 CerielloA.EspositoK.TestaR.BonfigliA

Anyone with serious weight-related or metabolic health concerns should work with healthcare providers rather than relying on supplements alone

Clinical trials comparing tirzepatide against semaglutide showed superior glycemic control and weight reduction with the dual agonist particularly at higher doses

The most common side effects for both medications are gastrointestinal: nausea, vomiting, diarrhea, constipation, reflux, and abdominal discomfort

Patients with pre-existing diabetic retinopathy should be aware that rapid improvement in blood glucose control may temporarily worsen retinopathy, particularly with semaglutide